Splenectomy protects against sepsis lethality and reduces serum HMGB1 levels

Journal of Immunology

Volumn 181, Issue 5, 2008, Pages 3535-3539

  Huston, Jared M ^a   Wang, Haichao ^b   Ochani, Mahendar ^a   Ochani, Kanta ^a   Rosas Ballina, Mauricio ^a   Gallowitsch Puerta, Margot ^a   Ashok, Mala ^b   Yang, Lihong ^a   Tracey, Kevin J ^a   Yang, Huan ^a  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE INHIBITOR; HIGH MOBILITY GROUP B1 PROTEIN; CASPASE; ENZYME INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; LETHALITY; LYMPHOCYTE; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; SEPSIS; SPLEEN; SPLENECTOMY; SURVIVAL; ANIMAL; BLOOD; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; MORTALITY; SURVIVAL RATE;

ANIMALS; APOPTOSIS; CASPASES; ENZYME INHIBITORS; HMGB1 PROTEIN; LYMPHOCYTES; MICE; SEPSIS; SPLEEN; SPLENECTOMY; SURVIVAL RATE;

EID: 51549108777     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.5.3535     Document Type: Article

References (26)

1. Angus, D. C., W. T. Linde-Zwirbleand, J. Lidicker, G. Clermont, J. Carcillo, and M. R. Pinsky. 2001. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29: 1303-1310.
2. Wang, H., O. Bloom, M. Zhang, J. M. Vishnubhakat, M. Ombrellino, J. Che, A. Frazier, H. Yang, S. Ivanova, L. Borovikova, et al. 1999. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285: 248-251. (Pubitemid 29329996)
3. Yang, H., M. Ochani, J. Li, X. Qiang, M. Tanovic, H. E. Harris, S. M. Susarla, L. Ulloa, H. C. Wang, R. DiRaimo, C. J. Czura, et al. 2004. Reversing established sepsis with antagonists of endogenous HMGB1. Proc. Natl. Acad. Sci. USA 101: 296-301.
4. Yang, H., H. Wang, C. J. Czura, and K. J. Tracey. 2005. The cytokine activity of HMGB1. J. Leukocyte Biol. 78: 1-8.
5. Wang, H., H. Liao, M. Ochani, M. Justiniani, X. Lin, L. Yang, Y. Al-Abed, H. Wang, C. Metz, E. J. Miller, et al. 2004. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat. Med. 10: 1216-1221. (Pubitemid 39540438)
6. Wang, H., H. Yang, and K. J. Tracey. 2004. Extracellular role of HMGB1 in inflammation and sepsis. J. Intern. Med. 255: 320-331. (Pubitemid 38324549)
7. Lotze, M. T., and K. J. Tracey. 2005. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nature Immunol. 5: 331-342.
8. O'Connor, K. A., M. K. Hansen, C. Rachal Pugh, M. M. Deak, J. C. Biedenkapp, E. D. Milligan, J. D. Johnson, H. Wang, S. F. Maier, K. J. Tracey, and L. R. Watkins. 2003. Further characterization of high mobility group box 1 (HMGB1) as a proinflammatory cytokine: central nervous system effects. Cytokine 24: 254-265.
9. Sappington, P. L., R. Yang, H. Yang, K. J. Tracey, R. L. Delude, and M. P. Fink. 2002. HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice. Gastroenterology 123: 790-802.
10. Abraham, E., J. Arcaroli, A. Carmody, H. Wang, and K. J. Tracey. 2000. HMG-1 as a mediator of acute lung inflammation. J. Immunol. 165: 2950-2954.
11. Qin, S., H. Wang, R. Yuan, H. Li, M. Ochani, K. Ochani, M. Rosas-Ballina, C. J. Czura, J. M. Huston, E. Miller, et al. 2006. Role of HMGB1 in apoptosis-mediated sepsis lethality. J. Exp. Med. 203: 1637-1642. (Pubitemid 44036267)
12. Hotchkiss, R. S., and I. E. Karl. 2003. The pathophysiology and treatment of sepsis. N. Engl. J. Med. 348: 138-150.
13. Hotchkiss, R. S., K. W. Tinsley, P. E. Swanson, K. C. Chang, J. P. Cobb, T. G. Buchman, S. J. Korsmeyer, and I. E. Karl. 1999. Prevention of lymphocyte cell death in sepsis improves survival in mice. Proc. Nat. Acad. Sci. 96: 14541-14546.
14. Wesche-Soldato, D. E., R. Z. Swan, C. S. Chang, and A. Ayala. 2007. The apoptotic pathway as a therapeutic target in sepsis. Curr. Drug Targets 8: 493-500. (Pubitemid 46672616)
15. Wesche, D. E., J. L. Lomas-Neira, M. Perl, C. S. Chung, and A. Ayala. 2005. Leukocyte apoptosis and its significance in sepsis and shock. J. Leukocyte Biol. 78: 325-337.
16. Wichmann, M. W., J. M. Haisken, A. Ayala, and I. H. Chaudry. 1996. Melatonin administration following hemorrhagic shock decreases mortality from subsequent septic challenge. J. Surg. Res. 65: 109-114.
17. Hotchkiss, R., K. C. Chang, P. E. Swanson, K. W. Tinsley, J. J. Hui, P. Klender, S. Xanthoudakis, S. Roy, C. Black, E. Grimm, et al. 2000. Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nat. Immunol. 1: 496-501.
18. Iwata, A., V. M. Stevenson, A. Minard, M. Tasch, J. Tupper, E. Lagasse, I. Weissman, J. M. Harlan, and R. K. Winn. 2003. Over-expression of Bcl-2 provides protection in septic mice by a trans effect. J. Immunol. 171: 3136-3141. (Pubitemid 37093537)
19. Jiang, W., C. W. Bell, and D. S. Pisetsky. 2007. The relationship between apoptosis and high-mobility group protein 1 release from murine macrophages stimulated with lipopolysaccharide or polyinosinic-polycytidylic acid. J. Immunol. 178: 6495-6503. (Pubitemid 46717433)
20. Bell, C. W., W. Jiang, C. F. Reich, III, and D. S. Pisetsky. 2007. The extracellular release of HMGB1 during apoptotic cell death. Am. J. Physiol. 291: C1318-C1325.
21. Shih-Ching, K., M. A. Choudhry, T. Matsutani, M. G. Schwacha, L. W. Rue, and I. H. Chaudry. 2004. Splenectomy differentially influences immune responses in various tissue compartments of the body. Cytokine 28: 101-108. (Pubitemid 39313081)
22. Baker, C. C., H. O. Gaines, and A. T. Niven-Fairchild. 1984. The effect of tuftsin and splenectomy on mortality after intra-abdominal sepsis. J. Surg. Res. 36: 499-502.
23. Huston, J. M., M. Ochani, M. Rosas-Ballina, H. Liao, K. Ochani, V. A. Pavlov, M. Gallowitsch-Puerta, M. Ashok, C. J. Czura, B. Foxwell, et al. 2006. Splenectomy inactivates the cholinergic anti-inflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J. Exp. Med. 203: 1623-1628.
24. Konigswieser, H. 1985. Incidence of serious infections after splenectomy in childhood. Prog. Pediatr. Surg. 18: 173-181.
25. Davidson, R. N., and R. A. Wall. 2001. Prevention and management of infections in patients without a spleen. Clin. Microbiol. Infect. 7: 657-660.
26. Waghorn, D. J., and R. T. Mayon-White. 1997. A study of 42 episodes of overwhelming post-splenectomy infection: is current guidance for asplenic individuals being followed? J. Infection 35: 289-294.